B3GNT3 and lung carcinoma: Besides, β1, 3-N-acetylglucosaminyltransferase-3(B3GNT3) was reported be abnormally expressed in lung cancer, and the overexpression of B3GNT3 is related to the poor prognosis of patients with lung cancer.